Emily Mullin
Emily Mullin will on Monday join OneZero, Medium’s technology and science publication, to cover biotechnology.
Mullen was previously a freelance writer who has had bylines in The Washington Post, The Wall Street Journal, Scientific American, National Geographic, The Atlantic, Science, Quartz, Pacific Standard, and The Baltimore Sun, among others.
Her areas of interest include gene therapy, CRISPR, consumer genetics, reproductive technology, brain implants, regenerative medicine, biohacking, and AI in medicine.
She has also worked as associate editor for biomedicine at MIT Technology Review, where she earned a Newsbrief Award from the D.C. Science Writers Association.
She earned her bachelor’s degree in journalism at Ohio University and a master’s in science writing from Johns Hopkins University.
Former CoinDesk editorial staffer Michael McSweeney writes about the recent happenings at the cryptocurrency news site, where…
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…
The Financial Times has hired Barbara Moens to cover competition and tech in Brussels. She will start…
CNBC.com deputy technology editor Todd Haselton is leaving the news organization for a job at The Verge.…
Note from CNBC Business News senior vice president Dan Colarusso: After more than 27 years…